Comparison of efficacy and pharmacoeconomics of two helicobacter pylori eradication regimens in peptic ulcer disease

Comparison of efficacy and pharmacoeconomics of two helicobacter pylori eradication regimens in peptic ulcer disease

Background: Helicobacter pylori, the cause of most peptic ulcer diseases, infects approximately 50% of the population worldwide. Indian data on cost and effectiveness of the standard first-line therapies for H. pylori eradication are scarce. Thus, the present study was aimed at comparing the cost an...

Full description

Bibliographic Details
Main Authors: Syeda Zaineb Kubra Hussaini, Syeda Zaineb Humaira Hussaini, Ruheena Yasmeen, Bader Unnisa, Aamir Ali Asgar Syed, Md Nematullah Khan, Syed Ibrahim Hassan
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2018-01-01
Series:Perspectives in Clinical Research
Subjects:
Cost-effectiveness analysis
Helicobacter pylori
peptic ulcer disease
perspective
pharmacoeconomics
Online Access:http://www.picronline.org/article.asp?issn=2229-3485;year=2018;volume=9;issue=1;spage=4;epage=8;aulast=Kubra

Internet

http://www.picronline.org/article.asp?issn=2229-3485;year=2018;volume=9;issue=1;spage=4;epage=8;aulast=Kubra

Similar Items